Pérez GY, Oyarzábal YA, Mas FR, Jiménez DS, Molina CV

Language: Spanish
References: 23
Page: 400-407
PDF size: 122.94 Kb.

ABSTRACT

Introduction: D-003, a mix of higher primary aliphatic acids purified from sugarcane, inhibits cholesterol synthesis. Recent studies have demonstrated that D-003 is effective in experimental models of osteoarthritis and inhibits the enzymatic activities of COX1 and COX2, mainly that of COX1, without causing gastrotoxicity. It has been mentioned that the dual inhibitors of COX and 5-LOX enzymes present with anti-inflammatory effects and no gastrotoxicity or even they can have gastroprotective actions. According to this background, D-003 could be a dual inhibitor of COX and 5-LOX enzymes.
Objective: to study the effects of D-003 on the enzymatic activity of 5-LOX in vitro, by using the cytosolic fraction of polymorphonuclear leukocytes of rats.
Methods: the following testing conditions were used: cytosolic fraction (50 µg of protein) dissolved into 0,2 mol/L borate buffer solution (pH 9) and linoleic acid (7,8-250 mmol/L) as substrate. Parallel samples were incubated with Tween-20/H₂O (2 %) only (vehicle), D-003 (0,6-6 000 µg/mL) or green-lipped mussel (Perna canaliculus) extract (50 µg/mL) (reference substance). The enzymatic activity, evaluated by the conjugated diene formation, was assessed by the absorbance changes at 234 nm (5-LOX) measured in a UV-visible spectrophotometer.
Results: by adding D-003, produced a dose dependent (r= 0,975; p‹ 0,05) (IC50= 23,06 µg/mL) in vitro inhibition of 5-LOX enzyme activity. The size of the inhibition was moderate, since the maximal inhibition, achieved from 1 250 µg/mL) on was only 30 %.
Conclusions: this study demonstrates that D-003 may inhibit in vitro the 5-LOX enzymatic activity, but in a moderate way.

REFERENCES

1. Mas R. D-003. A new substance with promising lipid modifying and pleiotropic effects for atherosclerosis management. Drugs Future. 2004;29:773-86.

2. Menéndez R, Mas R, Amor AM, Gonzalez RM, Jimenez S. Inhibition of cholesterol biosynthesis in cultured fibroblasts by D-003, a mixture of very long chain saturated fatty acids. Pharmacol Res. 2001;44:299-304.

3. Menéndez R, Mas R, Pérez Y, Amor AM, Gonzalez RM, Jimenez S. Inhibition of rat lipoprotein lipid peroxidation by the oral administration of D-003, a mixture of very long chain saturated fatty acids. Can J Physiol Pharmacol. 2002;80:13-21.

4. Castańo G, Menéndez R, Mas R, Amor AM, Fernandez J, Fernandez L, et al. Effects of D-003 on lipid profile and lipid peroxidation in healthy volunteers. Clin Drug Invest. 2003;23:193-203.

5. Mendoza S, Noa M, Valle M, Mas R, Mendoza N. Effects of D-003 on formaldehyde induced osteoarthritis in rats. Int J Pharm Sci Rev Res. 2012;16:21-4.

6. Mendoza S, Noa M, Valle M, Mas R, Mendoza N. Effects of D-003 on monoiodoacetate-induced osteoarthritis in rats. Int J Pharm Sci Rev Res. 2012 (Forthcoming).

7. Pérez Y, Mas R, Oyarzábal A, Molina V, Jimenez J. Effects of policosanol (sugar cane wax alcohols) and D-003 (sugarcane wax acids) on cyclooxygenase (COX) enzyme activity in vitro. Current Top Nutr Res. 2012 (Forthcoming).

8. Gámez R, Más R, Noa M, Pardo B, Pérez Y, González RM, et al. Acute and subchronic oral toxicity of D-003 in rats. Toxicol Letters. 2000;118:31-41.

9. Gámez R, Mas R, Noa M, Pardo B, Pérez Y, González RM, et al. Six-month toxicity study of oral administration of D-003 in Sprague Dawley rats. Drugs R&D. 2002;3:375-86.

10. Gámez R, Más R, Noa M, Pardo B, Pérez Y, González RM, et al. Effects of chronic administration of D-003, a mixture of sugar cane wax high molecular weight acids, in beagledogs. Drugs Exp Clin Res. 2004;30:75-88.

11. Gámez R, Noa M, Mas R, Pardo B, Pérez Y, González RM, et al. Long-term carcinogenicity of D-003, a mixture of high molecular weight acids from sugarcane wax, in Sprague Dawley rats: a 24 months study. Food Chem Tox. 2007;45:2352-8.

12. Ceballos A, Castańo G, Mendoza S, González J, Mas R, Fernandez J, et al. Effect of D-003 (10 mg/day) on the bone mineral density of the lumbar spine and femoral neck in postmenopausal women: a randomized, double-blinded study. Korean J Intern Med. 2011;26:168-78.

13. Lamarque D. Pathogenesis of gastroduodenal lesions induced by non-steroidal anti-inflammatory drugs. Gastroenterol Clin Biol. 2004;28:18-26.

14. Hudson N, Balsitis M, Everitt S, Hawkey CJ. Enhanced gastric mucosal leukotriene B4 synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut. 1993;34:742-7.

15. Nakamori Y, Komatsu Y, Kotani T, Kojima S, Takeuchi K. Pathogenic importance of cysteinyl leukotrienes in development of gastric lesions induced by ischemia/reperfusion in mice. J Pharmacol Exp Ther. 2010;333:91-8.

16. Cicero AF, Derosa G, Gaddi A. Combined lipoxygenase/cyclo-oxygenase inhibition in the elderly: the example of licofelone. Drugs Aging. 2005;22:393-403.

17. Singh VP, Patil CS, Kulkarni SK. Effect of licofelone against NSAIDs-induced gastrointestinal ulceration and inflammation. Indian J Exp Biol. 2005;43:247-53.

18. Coulson S, Vecchio P, Gramotnev H, Vitetta L. Green-lipped mussel (Perna canaliculus) extract efficacy in knee osteoarthritis and improvement in gastrointestinal dysfunction: a pilot study. Inflammopharmacology. 2012;20:71-6.

19. Mendez E, Marrero D, Gonzalez V, Vicente R, Mas R. GC determination of long chain fatty acids that compose D003 in 5 mg film coated tablets. J Pharm Biomed Analysis. 2003;31:613-20.

20. Boyum A. In iodinated density gradient media. A practical approach. IRL Press. 1983;2:147-70.

21. Tateson JE, Randall RW, Reynolds .H. Jackson W. Selective inhibition of arachidonate 5-ipoxygenase by a novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo. Br J Pharmacol. 1988;94:528-39.

22. Dugas B. Lyprinol inhibits LTB4 production by human monocytes. Allerg Immunol. 2000;32:284-9.

23. Pérez Y. Mas R. González R.M. Jiménez J. Molina V. Effects of D-003, a mixture of very long chain saturated fatty acids, and policosanol on in vivo lipid peroxidation in rats. Arzneim Forsch Drug Res. 2008;58:126-30.